True and apparent side effects in a controlled trial of chlorpromazine and imipramine in depression.
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced; D002746:Chlorpromazine / Q000009:adverse effects* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D003872:Dermatitis / Q000139:chemically induced; D004487:Edema / Q000139:chemically induced; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007099:Imipramine / Q000009:adverse effects* / Q000627:therapeutic use; D007565:Jaundice / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009127:Muscle Rigidity / Q000139:chemically induced; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D011605:Psychoses, Substance-Induced / Q000209:etiology; D014202:Tremor / Q000139:chemically induced
D007099:Imipramine; D002746:Chlorpromazine